Free Trial

Jamieson Wellness (TSE:JWEL) Stock Price Down 0.4% - Here's Why

Jamieson Wellness logo with Consumer Defensive background
Image from MarketBeat Media, LLC.

Key Points

  • Jamieson Wellness (TSE:JWEL) shares fell 0.4% to C$34.27 on Tuesday with just 36,634 shares traded, about a 56% decline from average volume, and the stock is trading below its 50- and 200-day moving averages.
  • Analysts are largely bullish—National Bank Financial, TD Securities and CIBC have raised price targets (to C$45–C$48), four analysts rate the stock a Buy, and the consensus price target is C$44.00.
  • On the fundamentals side, Jamieson posted quarterly EPS of C$0.90 on C$277.66M in revenue and pays a quarterly dividend of C$0.23 (annualized yield ~2.7%) with a payout ratio near 60%.
  • Interested in Jamieson Wellness? Here are five stocks we like better.

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) traded down 0.4% during trading on Tuesday . The stock traded as low as C$34.26 and last traded at C$34.27. 36,634 shares changed hands during mid-day trading, a decline of 56% from the average session volume of 84,085 shares. The stock had previously closed at C$34.40.

Wall Street Analyst Weigh In

JWEL has been the topic of a number of research analyst reports. National Bank Financial raised their price objective on shares of Jamieson Wellness from C$40.50 to C$45.00 and gave the stock an "outperform" rating in a report on Monday, February 23rd. TD Securities lifted their price objective on shares of Jamieson Wellness from C$46.00 to C$48.00 and gave the company a "buy" rating in a research report on Monday, March 2nd. Finally, Canadian Imperial Bank of Commerce set a C$43.00 price objective on shares of Jamieson Wellness and gave the company an "outperform" rating in a research report on Tuesday, March 24th. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of C$44.00.

Get Our Latest Report on JWEL

Jamieson Wellness Stock Performance

The stock's 50 day moving average price is C$35.71 and its 200 day moving average price is C$34.88. The company has a market cap of C$1.41 billion, a price-to-earnings ratio of 23.47 and a beta of 1.46. The company has a current ratio of 2.59, a quick ratio of 1.08 and a debt-to-equity ratio of 97.24.

Jamieson Wellness (TSE:JWEL - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported C$0.90 earnings per share (EPS) for the quarter. The firm had revenue of C$277.66 million during the quarter. Jamieson Wellness had a return on equity of 12.97% and a net margin of 7.60%. On average, analysts expect that Jamieson Wellness Inc. will post 2.1438892 EPS for the current fiscal year.

Jamieson Wellness Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 16th were paid a dividend of $0.23 per share. The ex-dividend date of this dividend was Friday, March 6th. This represents a $0.92 annualized dividend and a yield of 2.7%. Jamieson Wellness's dividend payout ratio (DPR) is currently 60.27%.

Jamieson Wellness Company Profile

(Get Free Report)

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jamieson Wellness Right Now?

Before you consider Jamieson Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.

While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines